Recent Updates
Recently added Catalysts
ADTX Negative Sentiment Score: 40/100

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on

Key Takeaway: Aditxt, Inc. announced a 1-for-27 reverse stock split effective May 18, 2026, following approval from stockholders at their annual meeting. This action, which will reduce the number of shares from approximately 13.8 million to about 510,000, is primarily aimed at meeting Nasdaq's minimum bid price requirement. The company plans to adjust outstanding warrants and stock options to align with this split. Aditxt aims to enhance its compliance and support its mission in accelerating health innovations amidst ongoing financial pressures.

Market Sentiment Analysis

POSITIVE FACTORS

  • Reverse stock split aims to comply with Nasdaq's minimum bid price requirement.
  • Company has received stockholder approval for the reverse stock split.
  • Aditxt is positioned as a social innovation platform driving health innovations.

CONCERNS & RISKS

  • The necessity of a reverse stock split indicates potential challenges in maintaining share price.
  • Aditxt currently has a substantial number of outstanding shares that will significantly decrease post-split.
  • Dependence on complying with Nasdaq listing standards indicates financial pressure.

Full Press Release Details

Aditxt, Inc. (NASDAQ:
ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026
Mountain View, Ca. (May 14, 2026) -Aditxt,
Inc. (Nasdaq: ADTX) ("Aditxt" or the "Company"), a social innovation platform
accelerating promising health innovations, announced today that it will effect a 1-for-27 reverse split of its common stock. Commencing
with the opening of trading on the Nasdaq Capital Market on May 18, 2026, the Company's common stock will trade on a post-split
basis under the same symbol ADTX. The reverse stock split was approved by the Company's stockholders at the annual meeting of stockholders
held on May 1, 2026, with the final ratio determined by the Company's board of directors.
of the reverse stock split, the CUSIP number for the Company's common stock will now be 007025869. As a result of the reverse stock
split, every 27 shares of issued and outstanding common stock will be exchanged for 1 share of common stock, with any fractional shares
being rounded up to the next higher whole share. Before the reverse stock split the Company will have approximately 13,773,321 shares
outstanding and immediately after the reverse stock split becomes effective, the Company will have approximately 510,123 shares of common
stock issued and outstanding.
will also be made to the Company's outstanding warrants and stock options. The number of shares into which these securities are convertible
or exercisable will be adjusted in line with the reverse split, as will the exercise prices of these securities.
reverse stock split is primarily intended to bring the Company into compliance with Nasdaq's minimum bid price requirement.
information concerning the reverse stock split can be found in Aditxt's definitive proxy statement filed with the Securities
and Exchange Commission on April 3, 2026.
Aditxt, Inc. is a social innovation platform
accelerating promising health innovations. Aditxt's ecosystem of research institutions, industry partners, and shareholders collaboratively
drives their mission to "Make Promising Innovations Possible Together." The innovation platform is the cornerstone of Aditxt's
strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model
that democratizes innovation, ensures every stakeholder's voice is heard and valued, and empowers collective progress.
Forward-Looking Statements
Certain statements in this press release constitute
"forward-looking statements" within the meaning of federal securities laws. Forward-looking statements include statements regarding
the Company's intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the expected
effects of the reverse stock split, the Company's ability to regain and maintain compliance with Nasdaq's minimum bid price
requirement and other continued listing standards, the timing of any actions by Nasdaq, and the Company's expectations, plans and
prospects. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those indicated
by these forward-looking statements as a result of various important factors, as well as market and other conditions and those risks more
fully discussed in the section titled "Risk Factors" in Aditxt's most recent Annual Report on Form 10-K, as well as discussions
of potential risks, uncertainties, and other important factors in the Company's other filings with the Securities and Exchange Commission.
All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events or otherwise, except as required by law.

Frequently Asked Questions

What is Aditxt's reverse stock split ratio?

Aditxt's reverse stock split ratio is 1-for-27.

When will the reverse stock split take effect?

The reverse stock split will take effect on May 18, 2026.

How many shares will Aditxt have after the split?

After the split, Aditxt will have approximately 510,123 shares outstanding.

Why is Aditxt implementing a reverse stock split?

The reverse stock split aims to help Aditxt comply with Nasdaq's minimum bid price requirement.

Where can I find more information about the split?

More information is available in Aditxt's definitive proxy statement filed on April 3, 2026.

Last updated: May 18, 2026